Document is current
Any future updates will be listed below
-
Authors
Polok, Kamil
Fronczek, Jakub
Guidet, Bertrand
Artigas, Antonio
De Lange, Dylan W.
Fjølner, Jesper
Leaver, Susannah
Beil, Michael
Sviri, Sigal
Bruno, Raphael Romano
Wernly, Bernhard
Pinto, Bernardo Bollen
Schefold, Joerg C.
Studzińska, Dorota
Joannidis, Michael
Oeyen, Sandra
Marsh, Brian
Andersen, Finn H.
Moreno, Rui
Cecconi, Maurizio
Flaatten, Hans
Jung, Christian
Szczeklik, Wojciech https://orcid.org/0000-0002-1349-1123
,
- License Information
-
More Information
Article History
Received: 3 June 2023
Accepted: 16 August 2023
First Online: 12 September 2023
Declarations
:
: Ethical approval was mandatory for the study participation in each country. The ethical consent procedures varied across participating countries []. In some countries recruitment without informed consent was allowed, while in others the collection of informed consent was mandatory.
: Not applicable
: Joerg C. Schefold declares that the Dept. of Intensive Care Medicine Bern has/had research and/or development/consulting contracts with (full disclosure): Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH/SA, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, and Nestlé. Educational grants were received from Fresenius Kabi; GSK; MSD; Lilly; Baxter; Astellas; AstraZeneca; B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Roba Pharma); Pfizer, Orion Pharma. The money went into departmental funds. No personal financial gain applies. All other authors do not have any conflict of interest to declare related to this manuscript.
